REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) Operating income 2019–2025
REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) annual operating income history from SEC filings — each fiscal year as reported.
-$20.2MFY2025 · since FY2019: -$724,740 → -$20.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$20.2M | +34.4% |
| FY2024 | -$30.8M | +22.0% |
| FY2023 | -$39.5M | -39.9% |
| FY2022 | -$28.2M | -179.4% |
| FY2021 | -$10.1M | -315.0% |
| FY2020 | -$2.4M | -235.9% |
| FY2019 | -$724,740 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More RVPH financial trends
RVPH RevenueRVPH Net incomeRVPH Net marginRVPH Gross profitRVPH Gross marginRVPH Operating marginRVPH Operating cash flowRVPH Free cash flowRVPH Capital expendituresRVPH Return on equityRVPH Stock buybacksRVPH Dividends paidRVPH Total assetsRVPH Total liabilitiesRVPH Shareholders’ equityRVPH overview →